Association study between interleukin-1β gene (IL-1β) and schizophrenia

Life Sciences

Volumn 72, Issue 26, 2003, Pages 3017-3021

  Yang, Jianzhong ^a   Si, Tianmei ^a   Ling, Yansu ^a   Ruan, Yan ^a   Han, Yonghua ^a   Wang, Xiling ^a   Zhou, Mo ^a   Zhang, Darong ^a   Zhang, Hongyan ^a   Kong, Qingmei ^a   Liu, Cui ^a   Li, Xueni ^a   Yu, Yaqin ^b   Liu, Shuzeng ^b   Shu, Liang ^a   Ma, Dalong ^c   Wei, Jun ^b   Zhang, Dai ^a  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b JILIN UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

Interleukin 1 (IL 1 ); Polymorphism; Schizophrenia; The transmission disequilibrium test (TDT)

Indexed keywords

INTERLEUKIN 1BETA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHINESE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FAMILIAL DISEASE; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETICS; HUMAN; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA;

EID: 0037449080     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00248-0     Document Type: Article

References (14)

1. Ganguli R., Yang Z., Shurin G., Chengappa K.N.R., Brar J.S., Gubbi A.V., Rabin B.S. Serum interlukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Research. 51:1994;1-10.
2. Gilmore J.H., Jarskog L.F. Exposure to infection and brain development: Cytokines in the pathogenesis of schizophrenia. Schizophrenia Research. 24:1997;365-367.
3. Hurme M., Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Europe Journal of Immunology. 28:1998;2598-2602.
4. Kay S.R., Fishbein A., Oppler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 13:1987;261-276.
5. Kendler K.S. The genetics of schizophrenia: an overview. Tsuang M.T., Simpson J.C. Handbook of Schizophrenia, Nosology, Epidemiology and Genetics of Schizophrenia. 1988;437-462 Elsevier, Amsterdam.
6. Lacosta S., Merali Z., Anisman H. Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology. 137:1998;351-361.
7. Maes M., Delange J., Ranjan R., Meltzer H.Y., Desnyder R., Cooremans W., Scharpe S. Acute phase proteins in schizophrenia, mania, and major depression: modulation by psychotropic drugs. Psychiatry Research. 66:1997;1-11.
8. McAllister CG, Van Kammen DP, Kelley ME, 1997. Relapse prediction in schizophrenia: from monoamines to cytokines. In: Ebert D, Ebmeier KP, Kaschka WP, Rechlin Th (Series Ed.). Advances in Biological Psychiatry, volume 18. In: Henneberg AE, Kaschka WP (Ed.), Immunological Alterations in Psychiatric Diseases. Karger., Basel, pp. 44-49.
9. Mehler M.F., Kessler J.A. Hematolymphopoetic and inflammatory cytokines in neural development. Trends in Neuroscience. 20:1997;357-365.
10. Merrill J.E. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: Normal and pathological. Developmental Neuroscience. 14:1992;1-10.
11. Potter E.D., Ling Z.D., Carvey P.M. Cytokine induced conversion of mesencephalic derived projenitor cells into dopamine neurons. Cell Tissue Research. 296:1998;235-246.
12. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission tests for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics. 52:1993;506-516.
13. Vitkovic L., Bockaert J., Jacque C. "Inflammatory" cytokines: Neuromodulators in normal brain? Journal of Neurochemistry. 74:2000;457-471.
14. Zhao B., Schwartz J.P. Involvement of cytokines in normal CNS development and neurological disease: recent progress and perspectives. Journal of Neuroscience Research. 52:1998;7-16.